US Edition
Published • loading... • Updated
Genome Editing for Biopharmaceutical Manufacturing
Surya Karunakaran, PhDDirector, Product ManagementATUM Chinese Hamster Ovary (CHO) cells have been the industrial workhorse for production of biopharmaceuticals since the 1980s, with the first CHO-derived product approved by the FDA in 1987. Nearly five decades later, CHO cells are the primary mammalian host for biopharmaceutical manufacturing due to their ease of manipulation, robust growth in high-density suspension cultures and post-translati…
1 Articles
1 Articles
Genome Editing for Biopharmaceutical Manufacturing
Surya Karunakaran, PhDDirector, Product ManagementATUM Chinese Hamster Ovary (CHO) cells have been the industrial workhorse for production of biopharmaceuticals since the 1980s, with the first CHO-derived product approved by the FDA in 1987. Nearly five decades later, CHO cells are the primary mammalian host for biopharmaceutical manufacturing due to their ease of manipulation, robust growth in high-density suspension cultures and post-translati…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
